Literature DB >> 18175231

Parental psychopathology as a predictor of long-term outcome in bulimia nervosa patients.

Aimee Arikian1, Pamela K Keel, Kathryn B Miller, Paul Thuras, James E Mitchell, Scott J Crow.   

Abstract

This paper sought to examine parental variables as predictors of long-term outcome in women with bulimia nervosa (BN). Participants were 94 treatment-seeking women with BN who were assessed at baseline, treatment end, and at follow-up (M=10.13 years). Participants reported rates of psychopathology and obesity in their mothers and fathers at baseline. The most frequently reported parental psychopathology was substance abuse in fathers. Chi-square analyses indicated that substance abuse in fathers was associated with poor treatment-end outcome in BN participants. Depression in mothers was associated with poor outcome at long-term follow-up, and obesity in mothers was associated with better outcome at long-term follow-up. A logistic regression analysis found that lifetime mood disorder in participants and severe depression in mothers were independent predictors of bulimic symptoms at long-term follow-up. The association between maternal severe depression and long-term outcome in BN suggests that specific parental variables may indicate longer course of BN.

Entities:  

Mesh:

Year:  2008        PMID: 18175231     DOI: 10.1080/10640260701771672

Source DB:  PubMed          Journal:  Eat Disord        ISSN: 1064-0266            Impact factor:   3.222


  2 in total

1.  Parental substance use history of overweight men and women with binge eating disorder is associated with distinct developmental trajectories and comorbid mood disorder.

Authors:  Kerstin K Blomquist; Robin M Masheb; Marney A White; Carlos M Grilo
Journal:  Compr Psychiatry       Date:  2011-02-05       Impact factor: 3.735

2.  Family histories of anxiety in overweight men and women with binge eating disorder: A preliminary investigation.

Authors:  Kerstin K Blomquist; Carlos M Grilo
Journal:  Compr Psychiatry       Date:  2015-07-17       Impact factor: 3.735

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.